查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198667

鼓膜切開術產品市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Tympanostomy Products Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2022 年至 2027 年），鼓膜切開術產品市場的複合年增長率預計為 1.9%。

COVID-19 大流行的出現正在影響鼓膜切開術產品的增長。 此外，封鎖和社會疏遠正在影響耳部手術，對鼓膜造口術產品市場產生負面影響。 此外，Sage Journals 於 2021 年 5 月發表的一篇題為“COVID-19 大流行對兒科鼓膜置管術的影響”的研究文章發現，在 COVID-19 大流行期間，兒科鼓膜置管術的置入率顯著增加。據報導，這種情況正在下降。 它還報告說，接受手術的患者年齡越來越大，越來越多的兒童在三級醫療機構得到照顧。 因此，COVID-19 正在影響市場的增長速度。

但是，耳部感染率上升等因素預計將推動市場增長。 例如，根據 2021 年 3 月發表的《急性中耳炎》報告，中耳炎最常見於 6 個月至 24 個月之間。 同一份資料還報告說，大約80%的兒童一生中都會患上中耳炎，而80%至90%的兒童在入學前會患上滲出性中耳炎。 這種耳部感染的增加增加了對鼓膜切開術的需求並促進了市場的增長。

此外，創新的鼓膜置管插入設備的開發和監管批准正在推動市場增長。 例如，2019 年 11 月，美國食品和藥物管理局向 Tusker Medical 宣布了一種名為 Tula System 的新系統，該系統用於輸送可插入鼓膜以治療復發性耳部感染（=中耳炎）的鼓室管。

然而，由於耳部感染的負擔不斷增加，該領域的技術進步加上監管部門的批准有望推動市場增長，儘管有替代方法可用。因此，這可能會阻礙預測期內的市場增長。

鼓膜切開產品市場趨勢

預計急性中耳炎在預測期內將顯著增長

預計急性中耳炎細分市場在預測期內將出現顯著增長。 隨著感染的增加，會在鼓膜上切開一個切口，以緩解積液過多造成的壓力，並從中耳排出膿液。 此外，在 2021 年，一項名為“用於兒童反復感染的耳管或抗生素”的研究報告稱，耳部感染是美國兒童最常見的疾病之一。 它是由感染鼓膜後面稱為中耳的耳朵部分的細菌或病毒引起的。 中耳的一部分腫脹或阻塞，導致鼓膜後面積聚液體。 此外，根據該雜誌，使用咽鼓管對這種感染是有利的。 像這樣的研究文章推動了市場的增長。 此外，耳部感染在兒童中比在老年人中更常見。 例如，2020 年 1 月發表的一篇題為“急性中耳炎”的 JAMA Pediatrians 論文報導，急性中耳炎是兒科醫生評估的最常見疾病之一。 根據同一數據，大約 50% 的兒童在兩歲生日前至少有過一次耳部感染。 兒童最易患 AOM 的年齡段是 3 個月至 24 個月。 這樣，人口增長和每名婦女生育數量的增加導致急性中耳炎的負擔增加，這是推高鼓膜造口術產品市場的一個因素。

北美擁有最大的鼓膜切開術產品市場份額

在中耳炎高發的北美地區，鼓膜造口產品市場份額最大。 鼓膜切開術管插入是美國兒童中最常見的外科手術之一。 例如，根據國家聾人研究所 2021 年 3 月發表的一篇論文，該國六分之五的兒童將在三歲時經歷耳部感染。 因此，預計該國耳部感染的高發率將推動市場研究。 此外，根據 2019 年 7 月發表在 The Connect hearing Canada 上的一篇文章，該國的耳部感染非常普遍，大約 50% 的 2 至 7 歲的加拿大兒童患有耳部感染。正在遭受感染。 此外，越來越多地採用技術先進的鼓膜切開術產品和改進的基礎設施正在推動該地區市場的增長。 此外，市場參與者之間為加強市場地位而進行的合作也推動了市場增長。 例如，2020 年 1 月，Smith & Nephew 收購了總部位於加州的 Tasker Medical（塔斯克）。 此次收購支持 Smith & Nephew 投資於解決未滿足臨床需求的創新技術的戰略。 因此，預計該地區的研究市場將在預測期內實現增長。

鼓膜切開術產品市場競爭分析

由於國際和區域參與者的存在，這個市場競爭相對激烈。 從市場份額的角度來看，鼓膜切開術產品市場由 Adept Medical Ltd、Atos Medical、Grace Medical、Integra LifeSciences Corporation 和 Olympus Corporation 等主要市場參與者主導。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查結果
  • 調查假設
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 耳部感染的患病率增加
    • 開發創新的鼓膜置管插入裝置
  • 市場製約因素
    • 替代療法的可用性
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品分類
    • 管插入器
    • 鼓膜切開管
  • 按材料
    • 矽
    • 氟樹脂
    • 其他材料
  • 通過使用
    • 急性中耳炎
    • 復發性中耳炎伴積液
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Atos Medical
    • EON Meditech Pvt. Ltd
    • Grace Medical
    • Integra LifeSciences Corporation
    • KOKEN Co. Ltd
    • Medtronic PLC
    • Olympus Corporation
    • Adept Medical Ltd
    • Preceptis Medical Inc.
    • Smith & Nephew
    • Summit Medical Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 68659

The tympanostomy products market is expected to register a CAGR of 1.9% during the forecast period (2022-2027).

The emergence of the COVID-19 pandemic has impacted the growth of tympanostomy products. Furthermore, the lockdowns and social distancing have impacted ear surgical procedures, adversely affecting the tympanostomy products market. Additionally, the Sage Journals research article titled ' The Effect of the COVID-19 Pandemic on Pediatric Tympanostomy Tube Placement' published in May 2021, reported that during the COVID-19 pandemic, the rate of pediatric tympanostomy tube placement has significantly decreased. It also reported that the age of patients undergoing surgery has increased, and more children are being cared for in a tertiary setting. Thus, the COVID-19 has impacted the pace of growth of the market.

However, factor such as the increasing prevalence of ear infection is expected to boost the growth of the market. For instance, according to the report "Acute Otitis Media" published in March 2021, otitis media is most commonly seen between the ages of 6 to 24 months. The same source also reported that approximately 80% of all children experience a case of otitis media during their lifetime, and between 80% to 90% of all children will have otitis media with an effusion before school age. Such increasing prevalence of ear infections fuels the need for tympanostomy and, hence, drives the market growth.

Moreover, the development of innovative tympanostomy tube insertion devices and approvals from the regulatory authority are propelling the market's growth. For instance, in November 2019, the US Food and Drug Administration approved a new system for the delivery of tympanostomy tubes that can be inserted into the eardrum to treat recurrent ear infections (i.e., otitis media) named Tula System to Tusker Medical.

However, owing to the rising burden of ear infection, technological advancement in the field, coupled with regulatory approval, is expected to fuel the growth of the market, but the availability of alternative methods may hinder market growth over the forecast period.

Tympanostomy Products Market Trends

Acute Otitis Media is Expected to Show Significant Growth during the Forecast Period

The acute otitis media segment is expected to show significant growth over the forecast period. The increased infection leads to the incision created in the eardrum to relieve pressure caused by excessive fluid buildup or drain pus from the middle ear. Additionally, in 2021, a study titled 'Ear tubes or antibiotics for repeat infections in children?' reported that ear infections were among the most common illnesses in US children. They occur when bacteria or viruses infect the area behind the eardrum called the middle ear. Parts of the middle ear become swollen or blocked, trapping fluid behind the eardrum. The same source also reported that using ear tubes in the infection is advantageous. Such research articles propel the growth of the market. Furthermore, ear infections are more common in children than they are in seniors. For instance, JAMA Pediatrians article titled 'Acute Otitis Media' published in January 2020, reported that acute otitis media is one of the most common illnesses evaluated by pediatricians. The same source also reported that about 50% of all children have at least one ear infection by the time they reach their second birthday. The most common age range in which children are likely to get AOM is 3 to 24 months. Thus, the rising population and more births per woman also contribute to the increasing burden of acute otitis media, hence boosting the tympanostomy products market.

North America holds the Largest Share in the Tympanostomy Products Market

The tympanostomy products market holds the largest share in the North American region due to the high prevalence of otitis media infection. Tympanostomy tube insertion is one of the most commonly performed surgical procedures among children in the United States. For instance, according to an article published by the National Institute on Deafness and Other Communication Disorders in March 2021, 5 out of 6 children in the country experience ear infection by the time they are three years old. Thus, the high incidence rate of ear infections in the country is expected to drive the market studied. Additionally, according to The Connect hearing Canada article published in July 2019, ear infections in the country are very common, and about 50% of children in Canada suffer from an ear infection between the ages of two to seven. Furthermore, the rising adoption of technologically advanced tympanostomy products and well-developed infrastructure boosts the growth of the market in the region. Additionally, the collaboration among the market players to strengthen their position in the market is also fueling the market's growth. For instance, in January 2020, Smith & Nephew acquired California-based Tusker Medical Inc. ("Tusker"). The acquisition supports Smith+Nephew's strategy to invest in innovative technologies that address unmet clinical needs. Thus, the studied market in the region is expected to project growth over the forecast period.

Tympanostomy Products Market Competitor Analysis

The market studied is moderately competitive with several international as well as regional players. In terms of market share, the tympanostomy products market is dominated by major market players such as Adept Medical Ltd, Atos Medical, Grace Medical, Integra LifeSciences Corporation, and Olympus Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalance of Ear Infection
    • 4.2.2 Development of Innovative Tympanostomy Tube Insertion Devices
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Therapies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Tube Inserters
    • 5.1.2 Tympanostomy Tubes
  • 5.2 By Material
    • 5.2.1 Silicone
    • 5.2.2 Fluoroplastic
    • 5.2.3 Other Materials
  • 5.3 By Application
    • 5.3.1 Acute Otitis Media
    • 5.3.2 Recurrent Otitis Media with Effusion
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Atos Medical
    • 6.1.2 EON Meditech Pvt. Ltd
    • 6.1.3 Grace Medical
    • 6.1.4 Integra LifeSciences Corporation
    • 6.1.5 KOKEN Co. Ltd
    • 6.1.6 Medtronic PLC
    • 6.1.7 Olympus Corporation
    • 6.1.8 Adept Medical Ltd
    • 6.1.9 Preceptis Medical Inc.
    • 6.1.10 Smith & Nephew
    • 6.1.11 Summit Medical Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS